Written question asked by Rehman Chishti (Conservative) on Thursday, 6 September 2018, in the House of Commons. It was due for an answer on Monday, 10 September 2018. It was answered by Caroline Dinenage (Conservative) on Thursday, 13 September 2018 on behalf of the Department of Health and Social Care.
Neuroblastoma: Research
- Question
-
To ask the Secretary of State for Health and Social Care, how much funding was allocated from the public purse to neuroblastoma research in 2016-17.
- Answer
-
Research is crucial in the fight against cancer. That is why the Department invests £1 billion per year in health research through the National Institute for Health Research (NIHR).
NIHR cancer research expenditure has risen from £101 million in 2010/11 to £137 million in 2016/17. This constitutes the largest investment in a disease area.
The NIHR spent approximately £1.26 million on neuroblastoma research in financial year 2016/17.
NIHR welcomes funding applications for research into any aspect of human health. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.
Secondary information
- Type
- Written question
- Reference
- 171360
- Session
- 2017-19
- Subjects
- Finance Research Neuroblastoma
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2023-05-12 12:08:23 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/171360
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/171360
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/171360